Taken together, SPOP/CHAF1A axis restricts tumor autophagy in a TFEB-dependent manner, and targeting TFEB-mediated signaling represents a useful strategy for SPOP-deficient DLBCL. The gene discussed is CHAF1A; the disease is diffuse large B-cell lymphoma.